Xylem Reports Solid Earnings Growth on Five Percent Organic Revenue Increase

  • Second quarter 2019 reported net income was $139 million or $0.77 per share; Adjusted net income for the quarter was $143 million or $0.79 per share, up 10% excluding foreign exchange translation
  • Delivered $1.3 billion in revenue for the second quarter, up 5% organically
  • Narrows full-year 2019 organic revenue growth guidance range to 5% to 6% and adjusted earnings per share to $3.12 to $3.22

RYE BROOK, N.Y.–(BUSINESS WIRE)–Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported second quarter 2019 net income of $139 million, or $0.77 per share. Excluding the impact of restructuring and realignment, the Company delivered adjusted net income of $143 million or $0.79 per share in the quarter. Excluding the impact of foreign exchange translation, adjusted earnings per share was up 10 percent. Second quarter revenue was $1.3 billion, up 5 percent organically with revenue growth across all end markets, led by double-digit growth in the U.S. and continued solid momentum in China and India. Reported operating margin in the quarter was 12.7 percent and adjusted operating margin was 14.3 percent, up 50 basis points compared to the prior year.

Patrick Decker, President and Chief Executive of Xylem, said “We have delivered another quarter of strong revenue growth and margin expansion. That consistent, organic orders and sales momentum – especially in the utilities market – reflects strong customer demand, and an equally strong focus on disciplined execution.”

Decker continued, “We are confident that our Xylem team will continue to deliver mid-single-digit growth and strong margin expansion in the second half of the year, despite seeing some slowing in Europe. As digitization of the water sector drives new demand, we’re seeing accelerating interest in our offerings. We continue to invest in technology and capabilities that deliver step-changes in performance and economics alongside water and energy savings.”

Full-year 2019 Outlook

Xylem is updating its forecasted full-year 2019 revenue outlook to be in the range of $5.29 to $5.38 billion. On an organic basis, Xylem’s revenue growth is narrowed to a range of 5 to 6 percent (2 to 3 percent on a reported basis) from previous guidance of 4 to 6 percent.

Xylem is revising its full-year 2019 adjusted operating margin outlook from 14.5 to 14.9 percent to 14.3 to 14.5 percent. The full-year adjusted earnings per share is now expected to be $3.12 to $3.22 from previous guidance of $3.12 to $3.32, an increase of 8 percent to 12 percent versus prior year. The Company’s adjusted earnings outlook excludes projected restructuring and realignment costs. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Second Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses primarily serving wastewater operations for utility and industrial customers through transport, dewatering and treatment applications.

  • Second quarter 2019 revenue was $561 million, up 6 percent organically compared with second quarter 2018. Double-digit growth in the U.S. from strength in the utilities and industrial end-markets led the performance in the quarter, partially offset by a slight decline in Western Europe.
  • Second quarter reported operating income for the segment was $98 million and adjusted operating income, which excludes $9 million of restructuring and realignment costs, was $107 million. The segment’s reported operating margin was 17.5 percent and adjusted operating margin was 19.1 percent, up 130 basis points versus the prior year as productivity, price realization and volume leverage offset inflation, unfavorable mix and growth investments.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses primarily serving the end users of water through industrial water management, commercial building services and residential applications.

  • Second quarter 2019 Applied Water revenue was $394 million, a 4 percent increase organically year-over-year, driven by healthy commercial and industrial end markets in the U.S. and Emerging Markets. Commercial was strong across most geographies from project activity.
  • Second quarter reported operating income for the segment was $62 million and adjusted operating income, which excludes $4 million of restructuring and realignment costs, was $66 million. The segment’s reported operating margin was 15.7 percent and adjusted operating margin was 16.8 percent, a 60 basis point increase over prior year period. Productivity and price realization more than offset inflation and unfavorable mix.

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses primarily serving the clean water and energy operations for utility and industrial customers through smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation applications.

  • Second quarter 2019 Measurement & Control Solutions revenue was $390 million, up 6 percent organically versus the prior year. Revenue growth was driven by strength in the North American water business.
  • Second quarter reported operating income for the segment was $26 million, and adjusted operating income, which excludes $8 million of restructuring and realignment costs, was $34 million. The segment’s reported operating margin was 6.7 percent. Adjusted operating margin was 8.7 percent, down 40 basis points versus the prior year as higher volume, price realization and productivity were more than offset by unfavorable mix and investments for growth in our new AIA platform and the pursuit of large AMI deployments.

Supplemental information on Xylem’s second quarter 2019 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s approximately 17,000 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York, with 2018 revenue of $5.2 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements include any statements that are not historical in nature, including any statements about the capitalization of Xylem Inc. (the “Company”), the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future — including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results — are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements.

Factors that could cause results to differ materially from those anticipated include: overall economic and business conditions, political and other risks associated with our international operations, including military actions, economic sanctions or trade barriers including tariffs and embargoes that could affect customer markets and our business, and non-compliance with laws, including foreign corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; weather conditions; ability to retain and attract talent and key members of management; our relationship with and the performance of our channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; uncertainty from the expected discontinuance of LIBOR and transition to any other interest rate benchmark; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; claims or investigations by governmental or regulatory bodies; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018 (“2018 Annual Report”) and with subsequent filings we make with the Securities and Exchange Commission (“SEC”).

All forward-looking statements made herein are based on information currently available to the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

 

 

Three Months

 

Six Months

For the period ended June 30,

2019

 

2018

 

2019

 

2018

Revenue

$

1,345

 

 

$

1,317

 

 

$

2,582

 

 

$

2,534

 

Cost of revenue

819

 

 

798

 

 

1,582

 

 

1,555

 

Gross profit

526

 

 

519

 

 

1,000

 

 

979

 

Selling, general and administrative expenses

294

 

 

293

 

 

597

 

 

589

 

Research and development expenses

47

 

 

50

 

 

98

 

 

91

 

Restructuring and asset impairment charges

14

 

 

5

 

 

25

 

 

15

 

Operating income

171

 

 

171

 

 

280

 

 

284

 

Interest expense

18

 

 

21

 

 

36

 

 

42

 

Other non-operating income, net

3

 

 

2

 

 

5

 

 

5

 

Gain (loss) from sale of business

 

 

(2

)

 

1

 

 

(2

)

Income before taxes

156

 

 

150

 

 

250

 

 

245

 

Income tax expense

17

 

 

35

 

 

32

 

 

51

 

Net income

$

139

 

 

$

115

 

 

218

 

 

194

 

Earnings per share:

 

 

 

 

 

 

 

Basic

$

0.77

 

 

$

0.64

 

 

$

1.21

 

 

$

1.08

 

Diluted

$

0.77

 

 

$

0.64

 

 

$

1.20

 

 

$

1.07

 

Weighted average number of shares:

 

 

 

 

 

 

 

Basic

180.0

 

 

179.8

 

 

179.9

 

 

179.8

 

Diluted

181.2

 

 

181.0

 

 

181.1

 

 

181.2

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

 

 

June 30,

2019

 

December 31,

2018

 

 

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

383

 

 

$

296

 

Receivables, less allowances for discounts and doubtful accounts of $31 and $35 in 2019 and 2018, respectively

1,096

 

 

1,031

 

Inventories

604

 

 

595

 

Prepaid and other current assets

175

 

 

172

 

Total current assets

2,258

 

 

2,094

 

Property, plant and equipment, net

661

 

 

656

 

Goodwill

2,999

 

 

2,976

 

Other intangible assets, net

1,211

 

 

1,232

 

Other non-current assets

545

 

 

264

 

Total assets

$

7,674

 

 

$

7,222

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

539

 

 

$

586

 

Accrued and other current liabilities

596

 

 

546

 

Short-term borrowings and current maturities of long-term debt

402

 

 

257

 

Total current liabilities

1,537

 

 

1,389

 

Long-term debt

2,051

 

 

2,051

 

Accrued postretirement benefits

396

 

 

400

 

Deferred income tax liabilities

305

 

 

303

 

Other non-current accrued liabilities

479

 

 

297

 

Total liabilities

4,768

 

 

4,440

 

 

 

 

 

Stockholders’ equity:

 

 

 

Common Stock – par value $0.01 per share:

 

 

 

Authorized 750.0 shares, issued 193.8 shares and 192.9 shares in 2019 and 2018, respectively

2

 

 

2

 

Capital in excess of par value

1,975

 

 

1,950

 

Retained earnings

1,770

 

 

1,639

 

Treasury stock – at cost 13.7 shares and 13.2 shares in 2019 and 2018, respectively

(526

)

 

(487

)

Accumulated other comprehensive loss

(327

)

 

(336

)

Total stockholders’ equity

2,894

 

 

2,768

 

Non-controlling interests

12

 

 

14

 

Total equity

2,906

 

 

2,782

 

Total liabilities and stockholders’ equity

$

7,674

 

 

$

7,222

 

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

 

For the six months ended June 30,

2019

 

2018

Operating Activities

 

 

 

Net income

$

 

218

 

 

$

 

194

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation

58

 

 

58

 

Amortization

69

 

 

74

 

Share-based compensation

16

 

 

16

 

Restructuring and asset impairment charges

25

 

 

15

 

(Gain) loss from sale of businesses

(1

)

 

2

 

Other, net

4

 

 

(7

)

Payments for restructuring

(12

)

 

(12

)

Changes in assets and liabilities (net of acquisitions):

 

 

 

Changes in receivables

(68

)

 

(68

)

Changes in inventories

(10

)

 

(87

)

Changes in accounts payable

(23

)

 

54

 

Other, net

(70

)

 

(38

)

Net Cash – Operating activities

206

 

 

201

 

Investing Activities

 

 

 

Capital expenditures

(129

)

 

(111

)

Acquisitions of businesses, net of cash acquired

(18

)

 

(430

)

Proceeds from sale of business

(2

)

 

 

Other, net

3

 

 

4

 

Net Cash – Investing activities

(146

)

 

(537

)

Financing Activities

 

 

 

Short-term debt issued, net

257

 

 

437

 

Short-term debt repaid

(113)

 

 

(54

)

Repurchase of common stock

(39

)

 

(58

)

Proceeds from exercise of employee stock options

8

 

 

4

 

Dividends paid

(87

)

 

(76

)

Other, net

(1

)

 

(1

)

Net Cash – Financing activities

25

 

 

252

 

Effect of exchange rate changes on cash

2

 

 

(9

)

Net change in cash and cash equivalents

87

 

 

(93

)

Cash and cash equivalents at beginning of year

296

 

 

414

 

Cash and cash equivalents at end of period

$

 

383

 

 

$

 

321

 

Supplemental disclosure of cash flow information:

 

 

 

Cash paid during the period for:

 

 

 

Interest

$

 

45

 

 

$

 

46

 

Income taxes (net of refunds received)

$

 

74

 

 

$

 

51

 

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

 

 

Three Months

 

Six Months

For the period ended June 30,

2019

 

2018

 

2019

 

2018

Revenue

$

1,345

 

 

$

1,317

 

 

$

2,582

 

 

$

2,534

 

Cost of revenue

819

 

 

798

 

 

1,582

 

 

1,555

 

Gross profit

526

 

 

519

 

 

1,000

 

 

979

 

Selling, general and administrative expenses

294

 

 

293

 

 

597

 

 

589

 

Research and development expenses

47

 

 

50

 

 

98

 

 

91

 

Restructuring and asset impairment charges

14

 

 

5

 

 

25

 

 

15

 

Operating income

171

 

 

171

 

 

280

 

 

284

 

Interest expense

18

 

 

21

 

 

36

 

 

42

 

Other non-operating income, net

3

 

 

2

 

 

5

 

 

5

 

Gain (loss) from sale of business

 

 

(2

)

 

1

 

 

(2

)

Income before taxes

156

 

 

150

 

 

250

 

 

245

 

Income tax expense

17

 

 

35

 

 

32

 

 

51

 

Net income

$

139

 

 

$

115

 

 

218

 

 

194

 

Earnings per share:

 

 

 

 

 

 

 

Basic

$

0.77

 

 

$

0.64

 

 

$

1.21

 

 

$

1.08

 

Diluted

$

0.77

 

 

$

0.64

 

 

$

1.20

 

 

$

1.07

 

Weighted average number of shares:

 

 

 

 

 

 

 

Basic

180.0

 

 

179.8

 

 

179.9

 

 

179.8

 

Diluted

181.2

 

 

181.0

 

 

181.1

 

 

181.2

 

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except per share amounts)

 

 

June 30,

2019

 

December 31,

2018

 

 

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

383

 

 

$

296

 

Receivables, less allowances for discounts and doubtful accounts of $31 and $35 in 2019 and 2018, respectively

1,096

 

 

1,031

 

Inventories

604

 

 

595

 

Prepaid and other current assets

175

 

 

172

 

Total current assets

2,258

 

 

2,094

 

Property, plant and equipment, net

661

 

 

656

 

Goodwill

2,999

 

 

2,976

 

Other intangible assets, net

1,211

 

 

1,232

 

Other non-current assets

545

 

 

264

 

Total assets

$

7,674

 

 

$

7,222

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

539

 

 

$

586

 

Accrued and other current liabilities

596

 

 

546

 

Short-term borrowings and current maturities of long-term debt

402

 

 

257

 

Total current liabilities

1,537

 

 

1,389

 

Long-term debt

2,051

 

 

2,051

 

Accrued postretirement benefits

396

 

 

400

 

Deferred income tax liabilities

305

 

 

303

 

Other non-current accrued liabilities

479

 

 

297

 

Total liabilities

4,768

 

 

4,440

 

 

 

 

 

Stockholders’ equity:

 

 

 

Common Stock – par value $0.01 per share:

 

 

 

Authorized 750.0 shares, issued 193.8 shares and 192.9 shares in 2019 and 2018, respectively

2

 

 

2

 

Capital in excess of par value

1,975

 

 

1,950

 

Retained earnings

1,770

 

 

1,639

 

Treasury stock – at cost 13.7 shares and 13.2 shares in 2019 and 2018, respectively

(526

)

 

(487

)

Accumulated other comprehensive loss

(327

)

 

(336

)

Total stockholders’ equity

2,894

 

 

2,768

 

Non-controlling interests

12

 

 

14

 

Total equity

2,906

 

 

2,782

 

Total liabilities and stockholders’ equity

$

7,674

 

 

$

7,222

 

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

 

For the six months ended June 30,

2019

 

2018

Operating Activities

 

 

 

Net income

$

 

218

 

 

$

 

194

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation

58

 

 

58

 

Amortization

69

 

 

74

 

Share-based compensation

16

 

 

16

 

Restructuring and asset impairment charges

25

 

 

15

 

(Gain) loss from sale of businesses

(1

)

 

2

 

Other, net

4

 

 

(7

)

Payments for restructuring

(12

)

 

(12

)

Changes in assets and liabilities (net of acquisitions):

 

 

 

Changes in receivables

(68

)

 

(68

)

Changes in inventories

(10

)

 

(87

)

Changes in accounts payable

(23

)

 

54

 

Other, net

(70

)

 

(38

)

Net Cash – Operating activities

206

 

 

201

 

Investing Activities

 

 

 

Capital expenditures

(129

)

 

(111

)

Acquisitions of businesses, net of cash acquired

(18

)

 

(430

)

Proceeds from sale of business

(2

)

 

 

Other, net

3

 

 

4

 

Net Cash – Investing activities

(146

)

 

(537

)

Financing Activities

 

 

 

Short-term debt issued, net

257

 

 

437

 

Short-term debt repaid

(113)

 

 

(54

)

Repurchase of common stock

(39

)

 

(58

)

Proceeds from exercise of employee stock options

8

 

 

4

 

Dividends paid

(87

)

 

(76

)

Other, net

(1

)

 

(1

)

Net Cash – Financing activities

25

 

 

252

 

Effect of exchange rate changes on cash

2

 

 

(9

)

Net change in cash and cash equivalents

87

 

 

(93

)

Cash and cash equivalents at beginning of year

296

 

 

414

 

Cash and cash equivalents at end of period

$

 

383

 

 

$

 

321

 

Supplemental disclosure of cash flow information:

 

 

 

Cash paid during the period for:

 

 

 

Interest

$

 

45

 

 

$

 

46

 

Income taxes (net of refunds received)

$

 

74

 

 

$

 

51

 

 

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or “adjusted”) measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

“Adjusted Operating Income”, “Adjusted Segment Operating Income”, “Adjusted Net Income” and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of “free cash flow” does not consider certain non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Sensus Acquisition Related Costs” defined as costs incurred by the Company associated with the acquisition of Sensus that are being reported within operating income. These costs include integration costs, acquisition costs, costs related to the recognition of the backlog intangible asset amortization recorded in purchase accounting.

Contacts

Media

Houston Spencer +1 (914) 323-5723

Houston.Spencer@xyleminc.com

Investors

Matt Latino +1 (914) 323-5821

Matthew.Latino@xyleminc.com

Read full story here

error: Content is protected !!